Literature DB >> 1027716

A lipid chemotactic factor from anaerobic coryneform bacteria including Corynebacterium parvum with activity for macrophages and monocytes.

R J Russell, R J McInroy, P C Wilkinson, R G White.   

Abstract

A lipid with chemoattractant (chemotactic) activity for mouse and guinea-pig macrophages and for human blood monocytes is released by anaerobic coryneform bacteria (including Corynebacterium parvum). The active lipid is associated with fibrillar structures which lie on the outside of the bacterial cell and are released spontaneously during growth. The lipid can also be extracted easily by a number of methods. The fibrils are loosely associated with a capsule-like structure composed largely of polysaccharide. Purification of the active lipid was achieved by chloroform-methanol extraction of the whole organisms yielding a chloroform-soluble fraction attracting mononuclear phagocytes at concentrations around 10 microgram/ml. The infra-red spectrum of this material showed lipid but no peptide or sugar. Thin-layer chromatography yielded twelve spots of which three had chemoattractant properties. The most active of these gave staining reactions consistent with the presence of phospholipid, the other two probably contained free fatty acids and triglycerides. Thin-layer electrophoresis also yielded an active phosphorus-containing spot. Saturated fatty acids of chain lengths found in the anaerobic coryne forms had weak monocyte-attractant activity. As the active material was progressively purified, its activity as a monocyte attractant weakened.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1027716      PMCID: PMC1445065     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  [ISOLATION OF ISOPENTADECANOIC AND ISOHEPTADECANOIC ACIDS FROM THE LIPIDS OF CORYNEBACTERIUM PARVUM].

Authors:  A H ETEMADI
Journal:  Bull Soc Chim Biol (Paris)       Date:  1963

3.  [ADJUVANT PROPERTIES OF CORYNEBACTERIUM PARVUM ON ANTIBODY PRODUCTION AND ON THE INDUCTION OF DELAYED HYPERSENSITIVITY TOWARD CONJUGATED PROTEINS].

Authors:  T NEVEU; A BRANELLEC; G BIOZZI
Journal:  Ann Inst Pasteur (Paris)       Date:  1964-05

4.  Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages.

Authors:  P C Wilkinson; G J O'Neill; K G Wapshaw
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

5.  Modified spray for the detection of phospholipids on thin-layer chromatograms.

Authors:  V E Vaskovsky; E Y Kostetsky
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

6.  Immunostimulation with bacterial phospholipid extracts.

Authors:  R M Fauve; B Hevin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

7.  Surface peptido-glycolipid filaments on Mycobacterium leprae.

Authors:  J Gordon; R G White
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

8.  Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica.

Authors:  J L Johnson; C S Cummins
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

9.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

10.  Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes.

Authors:  S R Turner; J A Campbell; W S Lynn
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  12 in total

1.  Chemical properties of the principle in C. parvum that produces splenomegaly in mice.

Authors:  V Riveros-Moreno; A Niblock
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

2.  Chemotaxis of mitogen-activated human lymphocytes and the effects of membrane-active enzymes.

Authors:  P C Wilkinson; J A Roberts; R J Russell; M McLoughlin
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

3.  Biphasic pattern of activation of the reticuloendothelial system by anaerobic coryneforms in mice.

Authors:  A A Otu; R J Russell; R G White
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

Review 4.  Recognition and response in mononuclear and granular phagocytes.

Authors:  P C Wilkinson
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

5.  Characterization of leukocyte chemotactic activity of bacteriocin from Streptococcus mutans Rm-10.

Authors:  Y Tsukamoto; S Fukutani; Y Takayama; H Fukushima; H Sagawa; M Mori
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

Review 6.  Microbial volatile compounds in health and disease conditions.

Authors:  Robin Michael Statham Thorn; John Greenman
Journal:  J Breath Res       Date:  2012-05-04       Impact factor: 3.262

7.  Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants.

Authors:  E J Glass; A B Kay
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

8.  Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.

Authors:  G F Webster; J J Leyden; M E Norman; U R Nilsson
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

9.  The effect of acidic polysaccharides and prostaglandin-like substances isolated from Propionibacterium acnes on granulocyte chemotaxis.

Authors:  J Belsheim; A Dalen; H Gnarpe; L Hellgren; O J Iversen; J Vincent
Journal:  Experientia       Date:  1979-12-15

10.  Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes.

Authors:  F Kobayashi; T Nagoya; T Koshi; Y Saino
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.